Decibel Therapeutics Becomes Fenway's First Lab Tenant

Courtesy of Decibel Therapeutics
Decibel Employees In The New Lab Space At Fenway's Van Ness Development

Fenway may be evolving into more than just a ballpark neighborhood, and just landed its first lab tenant.

Decibel Therapeutics moved into 32K SF at Samuels & Associates’ Van Ness building Tuesday, bringing 50 jobs and a 100% occupancy rate to the mixed-use development. The first lab tenant and biotech company in Fenway, Decibel is focused on discovering and developing medicines pertaining to hearing in its new state-of-the-art lab space and work environment. Van Ness, at 1325 Boylston St., is one block from Fenway Park. Built on spec, the mixed-use tower was fully leased one year after opening in the summer of 2015.

“Our new headquarters in the Fenway will enable us to bring our capabilities under one roof and sustain the cross-disciplinary exchange needed to conduct breakthrough science,” Decibel president and CEO Steve Holtzman said. “We are also pleased to be a pioneer in the Fenway; hearing loss is more than a medical condition — the ability to hear the crack of a bat at a ballgame or enjoy a great concert are emblematic of the contribution that hearing brings to the human experience.”

Continue reading this story with a free account

Log in or register
Sign up for more articles like this
Subscribe to Bisnow's Boston Newsletters
Related Stories

Developer Plans 595 Apartments At Woburn Transit Center

Boston City Council Votes To Eliminate Parking Minimums For New Housing Development

Cherry Creek West Excavation To Commence, Making Way For 13-Acre Redevelopment

Lack Of Available Medical Office Space In Boston Forces Tenants To Get Creative

Companies Led By 49ers CEO, Former Rockets Exec Launch Sports Real Estate Arm

Fenway Center Apartment Complex Trades For $193M: The Boston Deal Sheet

How The Investors Upgrading Boston's Old Office Towers Are Luring New Tenants

New Firm Seeks Funds For $250M Tysons Project With Conservative Vision

Judge Allows Exton Square Mall Redevelopment To Proceed, Slams 'Absurd' Rejection

Hoque Global's $450M Downtown Dallas Project Loses City Incentive

Lender Takes Control Of Vacant Somerville Lab Building Following Failed Sale

Developers Face I-35 Project Delays With Financing, Utilities Harder To Secure